Business
AstraZeneca vaccine: Two more countries restrict vaccine rollout over blood clot concerns – The Australian Financial Review
An arm’s length investigation is needed to sort out the blood clot issue plaguing the AstraZeneca vaccine, say medical experts.
It also applied to those with heparin-induced thrombocytopenia, who have an adverse immune reaction to the drug heparin and their platelet function is affected.
ATAGI reassured people there was no evidence of risk for those with a history of other clotting conditions and recommended the jabs for a list for conditions including deep venous thrombosis, a clot in the lung and low platelets.
The vaccine was also recommended for people with risk factors for clotting: such as smoking or using oral contraceptives;…
-
Noosa News22 hours agoFervor Wines label started during pandemic keeps father and son close
-
Business24 hours agoThese ASX 200 shares could rise 15% to 20%
-
Business23 hours agoEvery ASX 200 sector closed in the red last week. Here’s why
-
General17 hours agoAFLW Sunday: Chloe Molloy kicks wonder goal as Zippy Fish stars for Swans